Don’t see what you’re looking for? Use the search box on MDA’s Quest magazine.
Twelve new MDA grants help advance 'exciting time' in ALS research
Posted on Monday, February 4, 2013 - 09:39, By: Freelance
Twelve new grants totaling $3.6 million have been awarded in support of research studies that will explore the causes of, and potential treatments for, amyotrophic lateral sclerosis (ALS).
The grants fund six new ALS projects, each using a different mechanism to uncover the causes of the disease and potential treatments
Posted on Wednesday, February 1, 2012 - 10:00, By: Amy Madsen
Six new MDA grants totaling $2 million have been awarded to research projects seeking to uncover the basic mechanisms that drive ALS (amyotrophic lateral sclerosis), with an eye toward the development of future therapies. The grants took effect Feb. 1.
"It's exciting to see that recent scientific...
Posted on Thursday, September 1, 2011 - 10:50, By: Amy Madsen
In its latest round of funding this July, MDA awarded nine grants totaling more than $2.5 million to research projects focused on uncovering the causes of, and developing therapies for, amyotrophic lateral sclerosis (ALS).
The new grants were awarded to investigators at labs in the United States...
MDA funding has been approved for nine new research projects focused on understanding the causes of ALS or ways to slow down the disease process
Posted on Monday, August 22, 2011 - 15:02, By: Amy Madsen
MDA has awarded nine grants totaling more than $2.5 million to fund research projects focused on uncovering the causes of, and developing therapies for, amyotrophic lateral sclerosis (ALS, or Lou Gehrig's disease).
The new grants went to investigators at labs in the United States and Canada.
Posted on Tuesday, March 1, 2011 - 09:06, By: ALSN Staff
MDA has awarded eight new grants totaling nearly $2.5 million to fund research into the causes of, and potential therapies for, ALS.
The grants were reviewed and approved by the MDA Board of Directors in December 2010, based on recommendations from the MDA Scientific and Medical Advisory Committees...